Compound Detail
CHEMBL5993183
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL5993183 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | CSTNVZNXJBJIAB-UHFFFAOYSA-N |
2
Targets
2
Activities
1
Assay Types
0
PK Parameters
0
Publications
0
Known Names
Molecular Properties
434.9
MW (Da)
5.76
ALogP
4
HBA
1
HBD
72.2
PSA (Ų)
0.44
QED
1
Ro5 Violations
4
Rot. Bonds
Drug Information
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 2 meas. best 8.7
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Nuclear receptor ROR-gamma CHEMBL1293231 | IC50 | 8.7 | 8.7 | 2.0 | 1 |
| Nuclear receptor ROR-gamma CHEMBL1741186 | IC50 | 8.7 | 8.7 | 2.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Nuclear receptor ROR-gamma | IC50 | = | 2.0 | nM | 8.7 | Biological Assays: The compounds of the invention inhibit RORgammaT activity. Ac... | - |
| Nuclear receptor ROR-gamma | IC50 | = | 2.0 | nM | 8.7 | Biochemical TR-FRET Assay: To identify novel antagonists of RORgammaT, an assay ... | - |
Data from ChEMBL 36 via Core Engine